CB2 receptors in the brain: role in central immune function

Area of Science:

• Neuroimmunology
• Cannabinoid receptor research
• Central nervous system (CNS) immune function

Background:

• The cannabinoid receptor CB2 (CB2R) is increasingly recognized for its role in the CNS, primarily through microglia.
• Microglia, the resident immune cells of the CNS, express both CB1 and CB2 receptors, with CB2R levels modulated by cell activation state.

Purpose of the Study:

• To investigate the functional role of the cannabinoid receptor CB2 (CB2R) in microglial activity within the central nervous system (CNS).
• To determine how exogenous cannabinoids affect microglial chemotaxis in response to pathogens.

Main Methods:

• In vivo and in vitro experiments were conducted.
• Microglial chemotaxis assays were performed using Acanthamoeba culbertsoni as a stimulus.
• The effects of exogenous cannabinoids (delta-9-tetrahydrocannabinol and CP55940) on microglial response were analyzed via CB2R activation.

Main Results:

• The cannabinoid receptor CB2 (CB2R) is highly expressed on microglia in 'responsive' and 'primed' states, indicating a functional role.
• Exogenous cannabinoids, delta-9-tetrahydrocannabinol and CP55940, were shown to inhibit microglial chemotaxis through CB2R activation.
• This inhibition suggests a counteraction to pro-chemotactic endocannabinoids released in response to Acanthamoeba.

Conclusions:

• The cannabinoid receptor CB2 (CB2R) plays a critical immune functional role in the central nervous system (CNS).
• CB2R activation by exogenous cannabinoids can modulate microglial immune responses, specifically inhibiting chemotaxis.
• These findings highlight the potential of targeting CB2R for therapeutic interventions in CNS immune conditions.